Interviews

Finding Value in the Clinical Space: A Conversation with Iter Investments Founder Dustin Robinson

Dustin Robinson, Founder of psychedelic VC firm Iter Investments, recently sat down with InvestorPlace to discuss the emerging sector of psychedelic medicine. Here are some key takeaways: When asked about the possible breadth of clinical psychedelics, Robinson had this to say: The FDA responds to data. People respond to stories Large institutions like the FDA…

The New Health Club interview

Destigmatizing Psychedelics: A Conversation with Anne Philippi & Christoph Haberbauer of The New Health Club

Around the world, conversations about psychedelic medicine are starting to infiltrate everyday life. Major universities and nonprofits are funding groundbreaking research, private companies are raising hundreds of millions of dollars, and an entire new way to approach mental health is starting to materialize. However, despite much of this progress, psychedelic drugs are still viewed with…

magicmed joseph tucker

MagicMed: Finding the Derivative with Dr. Joseph Tucker

This morning, Monday May 24th, Enveric Biosciences (NASDAQ: ENVB) announced that it has entered an agreement to acquire privately held biotechnology company MagicMed Industries. MagicMed has a state-of-the-art facility at the University of Calgary, which it uses to perform extensive R&D on naturally occurring psychedelic molecules. Their focus is the discovery and early development of…